EBioMedicine is the premium gold open access venue for translational biomedical research. The journal is dedicated to publishing original research that elucidates, or aims to modify, disease pathways and mechanisms-with the goal of advancing our knowledge in any biomedical discipline with relevance to human health.''.
| YEAR | Impact Factor |
|---|---|
| 2020-21 | 3.44 |
| 2019 | 5.15 |
| 2018 | - |
EBioMedicine, 2352-3964/-, started opeartions from United Kingdom in year 2014, publish paper in Medicine (General) Monthly.